Denali Therapeutics (DNLI) Assets (2017 - 2025)
Historic Assets for Denali Therapeutics (DNLI) over the last 9 years, with Q3 2025 value amounting to $1.1 billion.
- Denali Therapeutics' Assets fell 2739.95% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 2739.95%. This contributed to the annual value of $1.4 billion for FY2024, which is 1908.83% up from last year.
- Denali Therapeutics' Assets amounted to $1.1 billion in Q3 2025, which was down 2739.95% from $1.2 billion recorded in Q2 2025.
- In the past 5 years, Denali Therapeutics' Assets registered a high of $1.6 billion during Q1 2024, and its lowest value of $1.1 billion during Q3 2025.
- In the last 5 years, Denali Therapeutics' Assets had a median value of $1.4 billion in 2024 and averaged $1.4 billion.
- Per our database at Business Quant, Denali Therapeutics' Assets surged by 13323.48% in 2021 and then plummeted by 2739.95% in 2025.
- Quarter analysis of 5 years shows Denali Therapeutics' Assets stood at $1.4 billion in 2021, then grew by 3.99% to $1.5 billion in 2022, then decreased by 20.98% to $1.2 billion in 2023, then rose by 19.09% to $1.4 billion in 2024, then fell by 23.18% to $1.1 billion in 2025.
- Its Assets stands at $1.1 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $1.3 billion for Q1 2025.